Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 51 citing articles:

Presenting clinical symptoms of post-COVID-19 breakthrough infection: Predictors of mortality in a Middle Eastern population
Asma S. Albtoosh, Randa Farah, Khaled Al Oweidat, et al.
Vaccine X (2024) Vol. 18, pp. 100495-100495
Open Access | Times Cited: 1
Effects of vaccination against COVID-19 on the emotional health of Peruvian older adults
Christoper A. Alarcon‐Ruiz, Zoila Romero-Albino, Percy Soto-Becerra, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Real-Time Monitoring of the Effectiveness of Six COVID-19 Vaccines against Laboratory-Confirmed COVID-19 in Hungary in 2021 Using the Screening Method
J Horváth, Tamás Ferenci, Annamária Ferenczi, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1824-1824
Open Access | Times Cited: 7
Effectiveness of COVID-19 Vaccines Against SARS-CoV-2 Infection During a Delta Variant Epidemic Surge in Multnomah County, Oregon, July 2021
Russell Barlow, Kevin Jian, Lindsey Larson
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
Megan Wallace, Jennifer P. Collins, Heidi L Moline, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278624-e0278624
Open Access | Times Cited: 6
Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland
Nanina Anderegg, Christian L. Althaus, Samuel Colin, et al.
Schweizerische medizinische Wochenschrift (2022) Vol. 152, Iss. 1516, pp. w30163-w30163
Open Access | Times Cited: 5
How Does Vaccination against SARS-CoV-2 Affect Hospitalized Patients with COVID-19?
Paloma Moreno‐Nunez, Aurora Bueno‐Cavanillas, Diego San José-Saras, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3905-3905
Open Access | Times Cited: 5
The long-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines: A systematic literature review and meta-analysis
Alexandre R. Marra, Takaaki Kobayashi, Hiroyuki Suzuki, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 4
Efficacy of approved vaccines to prevent COVID-19: a systematic review and network meta-analysis of reconstructed individual patient data from randomized trials
Alhassane Diallo, Miguel Carlos‐Bolumbu, Mamadou Diallo, et al.
Journal of Public Health (2022) Vol. 31, Iss. 9, pp. 1463-1472
Open Access | Times Cited: 4
Modeling the Transmission Dynamics of COVID-19 Among Five High Burden African Countries
Sebwedin Surur Jemal, Bizuwork Derebew Alemu
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1013-1029
Open Access | Times Cited: 4
Effects of vaccination against COVID-19 on the emotional health of older adults
Christoper A. Alarcon‐Ruiz, Zoila Romero-Albino, Percy Soto-Becerra, et al.
F1000Research (2023) Vol. 11, pp. 868-868
Open Access | Times Cited: 2
Evaluation of the Real-World Effectiveness of Vaccines against COVID-19 at a Local Level: Protocol for a Test-Negative Case–Control Study
Cátia Brazete, Marta Pinto, Lígia Sá, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 822-822
Open Access | Times Cited: 3
Digitalizing and Upgrading Severe Acute Respiratory Infections Surveillance in Malta: System Development
John Paul Cauchi, Maria‐Louise Borg, Aušra Džiugytė, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 12, pp. e37669-e37669
Open Access | Times Cited: 3
Impact of vaccination on SARS-CoV-2 transmission in the UK: a modelling study
Nieves Derqui, Swapnil Mishra, Wes Hinsley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The effectiveness of vaccines against COVID-19 in Mexico: A time series approach
David Flores, Edgar Luna
Vaccine (2024) Vol. 44, pp. 126565-126565
Closed Access
Establishing the African region monitoring vaccine effectiveness (AFRO-MoVE) network for respiratory pathogens
Céline Gurry, J.M. Mwenda, Anthony Nardone, et al.
Vaccine (2024), pp. 126616-126616
Open Access
Comparative Pharmacological Efficacy of COVID-19 Vaccines against the Variants of Concerns (VOCs) of SARS-CoV-2: Recent Clinical Studies on Booster Dose
Di Zhao, Xiaoyan Wang, Junqi Liu, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 24, Iss. 13, pp. 1603-1612
Closed Access | Times Cited: 1
Data Resource Profile: Results Analysis Base of Navarre (BARDENA)
Javier Gorricho, Leire Leache, Ibai Tamayo, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 6, pp. e301-e307
Open Access | Times Cited: 1
A Correlation Study of COVID-19 in Europe Considering Different Vaccines, Age Groups and Variants Including Delta and Omicron
Hasan Iqbal, Muhammad Umair, Syeda Amna Rizvi, et al.
BioMed (2022) Vol. 2, Iss. 2, pp. 133-169
Open Access | Times Cited: 2
Effectiveness of Comirnaty® Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study
Diego Fernández-Lázaro, Manuel Garrosa, Nerea Sánchez-Serrano, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1170-1170
Open Access | Times Cited: 2
COVID-19 vaccination effectiveness rates by week and sources of bias
Anna Ostropolets, George Hripcsak
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre study analysis by age-group, vaccine brand and time since vaccination, I-MOVE-COVID-19 and ECDC networks, July–August 2021
Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz, et al.
(2021)
Open Access | Times Cited: 2
Effects of vaccination against COVID-19 on the emotional health of older adults
Christoper A. Alarcon‐Ruiz, Zoila Romero-Albino, Percy Soto-Becerra, et al.
F1000Research (2022) Vol. 11, pp. 868-868
Open Access | Times Cited: 1
Impact of demographic, social and economic determinants in COVID-19 related outcomes in the middle-aged population of Navarre (Spain)
Leire Leache, Julián Librero, Marta Gutiérrez‐Valencia, et al.
Journal of Public Health (2023)
Closed Access
Necessity is the mother of invention: digitising national SARI surveillance in an island country (Preprint)
John Paul Cauchi, Maria‐Louise Borg, Aušra Džiugytė, et al.
(2022)
Closed Access

Scroll to top